Catalyst Pharmaceuticals, Inc. Liquidation Value

CPRX Other

Cash & Equivalents

$709.17M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $709.17M
Total Obligations: -$149.94M
$559.23M
Per share: $4.56
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $709.17M
AR: $126.48M
Total Obligations: -$149.94M
$685.71M
Per share: $5.60
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $709.17M
AR: $126.48M
Inventory: $37.17M
Total Obligations: -$149.94M
$722.88M
Per share: $5.90
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$559.23M$4.56
Liquid Liquidation Value$685.71M$5.60
Operating Liquidation Value$722.88M$5.90

Key Components (as of 2025-12-31)

Cash & Equivalents$709.17M
Accounts Receivable$126.48M
Inventory$37.17M
Current Liabilities$147.15M
Long-term DebtN/A
Op. Lease Liability$2.79M
Finance Lease$0
Shares Outstanding122.5M

Explore all 194 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$709.17M$126.48M$37.17M$11.20M$147.15MN/A$2.79M$0
2025-09-30$689.89M$106.41M$28.03M$9.10M$128.74MN/A$2.89M$0
2025-06-30$652.80M$65.86M$18.65M$5.53M$113.01MN/A$2.99M$0
2025-03-31$580.66M$71.27M$19.78M$11.20M$111.65MN/A$3.09M$0
2024-12-31$517.55M$65.48M$19.54M$16.59M$120.68MN/A$3.19M$0
2024-09-30$442.33M$58.27M$20.02M$11.56M$105.39MN/A$3.28M$0
2024-06-30$375.69M$57.17M$18.01M$7.12M$92.32MN/A$3.38M$0
2024-03-31$310.41M$60.49M$19.95M$10.26M$79.57MN/A$3.47MN/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-02-25 View
2025-09-30 10-Q 2025-11-05 View
2025-06-30 10-Q 2025-08-06 View
2025-03-31 10-Q 2025-05-07 View
2024-12-31 10-K 2025-02-26 View
2024-09-30 10-Q 2024-11-06 View
2024-06-30 10-Q 2024-08-07 View
2024-03-31 10-Q 2024-05-08 View

Community Notes

Loading notes...

Questions

Loading questions...